Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 3, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Property, Plant & Equipment (Net) (2024 - 2026)

Analysis

Revium Rx (RVRC) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 8.55 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 5.83 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 1.67 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 5.46 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 1.96 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 2.06 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 554.14 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 2.99 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 107.22 Mn
10 Revium Rx 86.84 Mn 85.34 Mn - 9,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9,000.00
Dec 31, 2025 10,000.00
Dec 31, 2024 9,000.00